🇫🇷 France Country × Condition
cystic fibrosis Clinical Trials in France
Active clinical trials for cystic fibrosis with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT06356246
Recruiting
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
Enrollment
400 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06273566
Recruiting
French Validation of the AdT-Physio Scale
Enrollment
121 pts
Country
🇫🇷 France
Pole Sante Grace de Dieu
View Trial → NCT07274631
Recruiting
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
Enrollment
470 pts
Country
🇫🇷 France
CHU de Reims
View Trial → NCT06147414
Recruiting
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Enrollment
550 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT06370962
Recruiting
Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Modulators
Enrollment
180 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → Frequently Asked Questions
How many cystic fibrosis clinical trials are active in France?
There are currently 5 active clinical trials for cystic fibrosis with sites in France, of which 5 are actively recruiting patients.
How can I join a cystic fibrosis clinical trial in France?
To join a cystic fibrosis clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cystic fibrosis trials in France?
Active cystic fibrosis trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.